JAKARTA. PT Kimia Farma Tbk (KAEF) prepared a number of strategies, both organic and non-organic, to achieve its growth target of 20% this year.
Finance Director at KAEF, Suharta Wijaya, said that to be able to grow quickly, KAEF will focus on its acquisition program. "Previously, KAEF had acquired 56.77% or 476.90 million shares of Phapros (PEHA) in March 2019. In the future, it will acquire two state-owned and private hospitals located in Jakarta, "he explained as quoted by Kontan.co.id, Wednesday (10/7).
KAEF spent more than Rp 1 trillion to acquire PEHA shares, with assistance from three state-owned banks. In addition, the remaining funds for the acquisition have also been prepared to immediately complete the acquisition of two hospitals that targeted to be completed this year.
Suharta explained that KAEF had explored new products in the cosmetics segment under the Marcks & Venus brand. KAEF targets cosmetic segment growth to reach 30%, and for it to contribute 25% of the company's total revenue. (AM/AR)